Craniopharyngiomas are brain tumors that negatively impact the hormonal function of the nearby pituitary. The tumor location ...

Craniopharyngioma (CP) is a rare brain tumor that develops in the regions close to the hypothalamus and pituitary gland. The ...

Superior quality cytokines are crucial for reliable research results and the safe production of cancer cell therapies.

The immunosuppressive nature of the tumor microenvironment (TME) exerts oxidative stress on both native and infused T-cells, ‘exhausting them’. Mehrotra’s lab explores ways to minimize this exhaustion ...

Craniopharyngioma (CP) is a rare brain tumor that develops in the regions close to the hypothalamus and pituitary gland. The CP tumors lead to ...

The study reveals IL-15's role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

The research also showed that using TME with existing investigative methods offers critical new insights into Parkinson's disease by revealing how the proteins behave in living blood cells—a ...

In addition, this bispecific antibody activates immune cells within the tumor microenvironment (TME). This new therapeutic strategy has been evaluated in patient-derived models of HER2+ P95HER2 ...